Valeant Announces Q2 2017 Financial Results Date And Conference Call Details

LAVAL, Quebec, July 10, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it plans to release second quarter 2017 financial results on Tuesday, Aug. 8, 2017. The Company will host a conference call and live webcast at 8:00 a.m. EDT to discuss the results and provide a business update. All materials will be made available on the investor relations portion of the corporate website before the start of the conference call.

Conference Call Details

    Date            Tuesday, Aug. 8, 2017

    Time            8:00 a.m. EDT

    Webcast         http://ir.valeant.com/events-and-presentations

    Participant
     Event Dial-in  (877) 876-8393 (North America)

                    (443) 961-0178 (International)

    Participant
     Passcode                                                      35736021

    Replay Dial-in  (855) 859-2056 (North America)

                    (404) 537-3406 (International)

    Replay Passcode 31833 (replay available until Oct. 8, 2017)

About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.

    Investor Contacts:

    Arthur Shannon             Elif McDonald

    arthur.shannon@valeant.com elif.mcdonald@valeant.com

    514-856-3855               514-856-3855

    877-281-6642 (toll free)   877-281-6642 (toll free)

    Media Contact:

    Lainie Keller

    lainie.keller@valeant.com

    908-927-0617

View original content with multimedia:http://www.prnewswire.com/news-releases/valeant-announces-q2-2017-financial-results-date-and-conference-call-details-300485451.html

SOURCE Valeant Pharmaceuticals International, Inc.